Azenta, Inc. 8K

Azenta Germany GmbH and Thelema S.à r.l. amended their share purchase agreement for B Medical Systems to convert USD 35 million of the purchase price into a secured vendor loan and adjust the completion cash payment and timing accordingly.

On July 1, 2026, Azenta Germany GmbH and Thelema S.à r.l. executed a deed of amendment to their December 23, 2025 share purchase agreement for the sale of the entire issued share capital of B Medical Systems S.à r.l., revising the purchase price mechanics so that USD 35,000,000 of the consideration will be provided as a vendor loan from the Seller to the Buyer under a newly defined Vendor Loan Agreement, secured by a Luxembourg law share pledge over B Medical Systems, and reducing the cash payable at completion to USD 19,000,000 (purchase price minus the seller loan amount and deposit), while also extending the completion date reference from March 31, 2026 to July 1, 2026 and updating the conditions precedent and completion deliverables to include executed counterparts of the Vendor Loan Agreement and Share Pledge Agreement, all under Luxembourg governing law and jurisdiction.

Filing Facts

CIK

933974

Ticker

-

Form

8K

Source Type

sec

Accession

0001628280-26-047591

Alert Tier

7